• SENSEX 80,242.24
    -46.14 (--0.06%)
  • BANKNIFTY 55,087.15
    -304.10 (--0.55%)
  • Reliance Industr
    1,411.85 1,608.95(%)
  • Mazagon Dock
    3,149.70 3,149.70(%)
  • Bajaj Finance
    8,560.00 6,376.55(%)
  • Garden Reach Sh.
    1,855.00 890.05(%)
  • Cochin Shipyard
    1,575.50 1,169.00(%)
  • Tata Motors
    641.10 542.55(%)
  • Hind.Aeronautics
    4,466.00 3,045.95(%)
  • Paras Defence
    1,469.00 1,592.75(%)
  • Torrent Pharma.
    3,300.00 2,513.05(%)
  • Sonata Software
    446.50 762.00(%)
  • Data Pattern
    2,450.00 1,350.50(%)
  • IndusInd Bank
    843.10 1,550.00(%)
  • Samvardh. Mothe.
    131.75 107.30(%)
  • Bharat Electron
    312.50 221.00(%)
  • Trent
    5,130.00 4,197.50(%)
  • Varun Beverages
    507.45 419.40(%)
  • ICICI Bank
    1,415.10 1,051.50(%)
  • Vedanta
    423.20 527.00(%)
  • Hitachi Energy
    14,879.00 16,534.50(%)
  • Tech Mahindra
    1,510.60 1,807.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Divis Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 21188.0
  • ISIN : INE361B01024
6,087.00 -21 (-0.34%)
  • As on 30 Apr 2025 (EOD)
  • Today’s Low

    6,015.50
  • Today’s High

    6,136.00
  • Open

    6,115.50
  • Perv Close

    6,108.00
  • 52W Low

    3,724.00
  • 52W High

    6,308.50

Key Indicators

  • P/E(TTM)

    77.94

  • Mar.Cap (₹Cr.)

    161,590.72

  • Div & Yield %

    0.49

  • Book Value(₹)

    513.62

  • Debt-Equity Ratio

    -0.34

  • AGM Date

    30-Apr-2025

  • EPS

    78.09

  • P/E Ratio

    77.94

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    161,590.72

  • RONW (%)

    12.15

  • ROCE (%)

    16.41

Score Board

  • Equity (₹ in Cr.)

    53.09

  • BV (₹)

    513.60

  • Sales( ₹ in Cr.)

    7,665.00

  • NP (in Cr.)

    1,575.26

  • NP Var(%)

    -13.0

  • Div%

    1500.0

  • CPS (₹)

    73.50

  • EPS (₹)

    59.30

  • Traded Value (₹ in Lakhs)

    162,251.74

  • 52 Week High

    6,308.50

  • 52 Week Low

    3,724.00

  • Price BSE

    6112.0

  • Price NSE

    6,108.00

  • Market Capital( in Cr.)

    162,251.74

  • P/C Ratio

    83.20

  • P/E Ratio

    103.00

  • Price Vs.BV

    59.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 7,665.00 7,625.00 8,879.82 6,798.61 5,310.57 4,879.66
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 7,665.00 7,625.00 8,879.82 6,798.61 5,310.57 4,879.66
Other Income 337.00 349.00 111.26 62.53 189.86 156.58
Stock Adjustments 127.00 -50.00 449.99 100.00 94.10 244.22
Total Income 8,129.00 7,924.00 9,441.07 6,961.14 5,594.53 5,280.46
EXPENDITURE :            
Raw Materials 3,270.00 3,035.00 3,499.18 2,416.47 2,223.95 2,120.64
Power and Fuel Cost 477.00 496.00 390.05 319.15 280.73 248.78
Employee Cost 1,067.00 953.00 926.55 808.68 608.36 530.72
Other Manufacturing Expenses 299.00 285.00 255.38 202.29 184.36 138.96
Selling and Administration Expenses 367.00 402.00 340.16 292.53 222.86 171.84
Miscellaneous Expenses 137.00 55.00 40.95 37.69 68.00 62.87
Employee Benefit Expenses 1,067.00 953.00 926.55 808.68 608.36 530.72
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 5,617.00 5,226.00 5,452.27 4,076.81 3,588.26 3,273.81
Operating Profit 2,512.00 2,698.00 3,988.80 2,884.33 2,006.27 2,006.65
Interest 4.00 2.00 1.73 1.81 7.03 4.61
Gross Profit 2,508.00 2,696.00 3,987.07 2,882.52 1,999.24 2,002.04
Depreciation 376.00 342.00 310.55 254.65 185.95 168.81
Profit Before Tax 2,132.00 2,354.00 3,676.52 2,627.87 1,813.29 1,833.23
Current Tax 511.00 438.00 637.20 609.05 387.79 472.45
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 45.00 108.00 90.78 64.10 52.79 28.13
Reported Net Profit 1,576.00 1,808.00 2,948.54 1,954.72 1,372.71 1,332.65
Extraordinary Items 0.74 3.07 -1.65 -2.45 41.46 18.78
Adjusted Net Profit 1,575.26 1,804.93 2,950.19 1,957.17 1,331.25 1,313.87
Adjustment below Net Profit -1.00 2.00 2.18 0.16 -92.52 -53.52
P & L Balance brought forward 10,922.00 9,967.00 7,588.31 5,814.44 5,636.87 4,761.92
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 772.00 855.00 571.50 181.01 1,102.62 404.18
P & L Balance carried down 11,725.00 10,922.00 9,967.53 7,588.31 5,814.44 5,636.87
Dividend 0.00 0.00 0.00 0.00 424.75 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 1,500.00 1,500.00 1,500.00 1,000.00 800.00 800.00
Dividend Per Share(Rs) 30.00 30.00 30.00 20.00 16.00 16.00
Earnings Per Share-Unit Curr 59.47 68.23 111.08 73.64 51.71 50.20
Earnings Per Share(Adj)-Unit Curr 59.47 68.23 111.08 73.64 51.71 50.20
Book Value 508.83 479.43 440.44 349.28 275.63 262.70
Book Value(Adj)-Unit Curr 508.83 479.43 440.44 349.28 275.63 262.70

Shareholding Pattern

  • Promoter Group

    51.89%

  • Public Share Holding

    48.11%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 8,000,000 3.01 800,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 129,755,090 48.88 129,755,090 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 137,755,090 51.89 130,555,090 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 2,492 0.00 2,492 3
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 173,198 0.07 173,198 5
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 47,812,211 18.01 47,812,211 813
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 19,201,770 7.23 19,201,770 28
Mutual Funds / UTI 34,048,631 12.83 34,048,631 39
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,544,888 0.58 1,544,888 34
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 102,783,190 38.72 102,783,190 922
2] Non Institution
Bodies Corporate 3,302,683 1.24 3,302,683 1,944
Clearing Members 5,429 0.00 5,429 12
Directors of their Relatives 811,881 0.31 811,881 12
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,331,914 0.50 1,331,914 10,356
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 315,071 0.12 315,071 3,481
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,286,500 0.48 1,286,500 7
Individuals holding nominal share capital up to Rs. 1 lakh 17,756,107 6.69 17,681,696 250,979
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 93,211 0.04 93,211 33
Others 27,504 0.01 27,504 3
Sub Total 24,930,300 9.39 24,855,889 266,827
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 265,468,580 100.00 258,194,169 267,755

Company Background

Divis Laboratories LtdPharmaceuticals - Indian - Bulk Drugs

  • Divis Laboratories Ltd
  • BSE Code : 21188.0
  • ISIN : INE361B01024
  • Incorporation Year

    1990

  • Registered Office

    1-72-23(P)/DIVIS/303 Divi Towe
    Cyber Hills Gachibowli, Hyderabad,
    Telangana-500032

  • Telephone

    91-40-23786300/23786352/400

  • FAX

    91-40-23786460

  • Chairman

    Ramesh B V Nimmagadda

  • Managing Director

    Murali K Divi

  • Company Secretary

    Satish Choudhury

  • Auditor

    Price Waterhouse Chartered Accountants LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Divis Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Divi's Lab. 6,086.15 8,002.00 7,665.00 77.94 16.27
Abbott India 29,876.95 6,097.18 5,848.91 47.58 44.71
Astrazeneca Phar 8,665.50 1,330.33 1,295.53 223.40 33.26
P & G Health Ltd 5,072.65 1,166.89 1,151.26 35.59 39.76
Glaxosmi. Pharma 2,959.45 3,530.73 3,407.25 58.85 44.44
Cipla 1,549.65 17,645.00 16,574.34 26.57 20.10
Amrutanjan Healt 692.80 437.58 421.23 40.61 20.84
Guj. Themis Bio. 272.65 174.19 169.82 56.45 44.82
Fermenta Biotec. 260.70 315.24 307.09 24.71 4.10
Bliss GVS Pharma 119.00 638.96 605.46 27.23 11.19
Ambalal Sarabhai 36.46 11.70 3.81 15.58 1.92